|
⚲
|
| Keyboard |
| Westlake Biopartners Opportunity GP I LLC | |
|---|---|
| Firm | Westlake Biopartners LLC |
| Address | 3075 Townsgate Road, Suite 140 Westlake Village, CA 91361 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Westlake Biopartners LLC | |||||
| Westlake Biopartners Opportunity Fund I LP | 021-370270 | Director | 100.0 M of 100.0 M |
113.9 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2025-12-18 | Buy | 133,333 | $7.50 | 999,998 |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Conversion | 735,984 | ||
|
Kyverna Therapeutics Inc KYTX
Series A-2 Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 8,830,901 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Conversion | 3,787,940 | ||
|
Kyverna Therapeutics Inc KYTX
Series B Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 3,349,538 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Series A-1 Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 4,401,771 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Series B Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 4,006,624 | $0.00 |